Home
About
Overview
Sharing Data
ORCID
Help
History (38)
Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.
Depressive symptoms, cognitive decline, and risk of AD in older persons.
Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
Role of glycolytically generated ATP for CaMKII-mediated regulation of intracellular Ca2+ signaling in bovine vascular endothelial cells.
Objective changes in motor function during placebo treatment in PD.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Objective changes in motor function during placebo treatment in PD.
Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4.
View in:
PubMed
subject areas
Aged
Female
Humans
Male
Middle Aged
Movement
Parkinson Disease
Placebos
authors with profiles
Sue Leurgans